We value your privacy

This website or its third-party tools process personal data. You can opt out of the sale of your personal information by clicking on the “Do Not Sell or Share My Personal Information” link.

Powered by

TOSYMRA

ACNU Feasibility

View full report
GoodTOSYMRA nasal spray carries moderate safety risks, including side effects and interactions, requires cardiovascular monitoring, and has simple dosing with low misuse potential, reflecting key FDA ACNU considerations for safety, usability, and special population precautions.

ACNU Feasibility Scorecard

Chart with 11 data points.
TOSYMRA
The chart has 1 X axis displaying categories.
The chart has 1 Y axis displaying ← Lower is Better!. Data ranges from 1 to 5.
End of interactive chart.